Portside Wealth Group, LLC Novartis Ag Transaction History
Portside Wealth Group, LLC
- $578 Billion
- Q4 2024
A detailed history of Portside Wealth Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Portside Wealth Group, LLC holds 4,363 shares of NVS stock, worth $504,231. This represents 0.09% of its overall portfolio holdings.
Number of Shares
4,363
Previous 4,375
0.27%
Holding current value
$504,231
Previous $503 Million
0.27%
% of portfolio
0.09%
Previous 0.09%
Shares
7 transactions
Others Institutions Holding NVS
# of Institutions
1,479Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.41 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.27 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$946 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$794 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$645 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $249B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...